GLNS has advised the founders and managing directors of Smile Eyes Group, Dres. Wiltfang and Bechmann, on an investment by European private equity firm Trilantic Europe. The transaction is structured as a partnership between Trilantic Europe, the two founders of Smile Eyes and the management team with the intention of implementing a buy-and-build strategy in the German ophthalmology market.
Smile Eyes is a leading and highly specialised healthcare provider with a comprehensive range of services in the field of ophthalmology in various metropolitan regions in Germany. Smile Eyes stands for laser eye and lens surgery at the highest medical level and continuously invests in innovation and research to provide its patients with the best treatment options available.
Trilantic Europe is a pan-European private equity firm focused on midmarket transactions in Europe in the healthcare, consumer and leisure, industrial, TMT and business services sectors.
GLNS advised the founders with a team consisting of Partners Ludger Schult (Private Equity/M&A), Andreas Scheidle (Taxes) and Anselm Lenhard (Finance) and Associate Jennifer Blümlein (Private Equity/M&A).
PSP Munich with Partner Alexander Reichl and Associated Partner Benedikt Wiedmann were responsible for the tax structuring.
Trilantic was advised by the law firm Latham & Watkins LLP.